Marjon H. Cnossen

MD, PhD, professor
Department of Pediatric Hematology and Oncology, Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands
Rotterdam, Zuid-Holland, Netherlands

Presentation(s):

• PB0278 - Current practice regarding Bleeding Disorder of Unknown Cause (BDUC) in the Netherlands: a national survey

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0285 - Diagnosing and treating Bleeding Disorder of Unknown Cause: an illustrated review on current practice and future directions

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0279 - Feasibility, measurement properties and relevance of generic PROMIS item banks in adults with von Willebrand disease, platelet function disorders, and rare bleeding disorders

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0280 - Patient perspective of the burden and severity of von Willebrand disease

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 37.1 - Advanced hemostasis testing by quantitative proteomics

  Monday, June 24, 2024
  09:30 – 09:45 ICT

• OC 39.5 - Enhanced thrombin and plasmin generation profiles in alpha-2-antiplasmin deficient patients: Data from the RBiN study

  Monday, June 24, 2024
  10:30 – 10:45 ICT

• PB0640 - Experiences of young patients with hemophilia and their caregivers: A qualitative interview study

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0609 - Hemophilia care in the Netherlands: Identification and visualization of the care pathway for young children with hemophilia

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 73.4 - Personalized treatment by pharmacokinetic-guided dosing in von Willebrand disease; A prospective multicenter study, OPTI-CLOT/To WiN study

  Wednesday, June 26, 2024
  11:00 – 11:15 ICT